69489-07-2

Basic information

• Product Name: BOC-4-AMINO-3-HYDROXYBUTANOIC ACID
• Synonyms: BOC-4-AMINO-3-HYDROXYBUTANOIC ACID;4-(Boc-amino)-3-hydroxy-butanoic acid;4-(tert-butoxycarbonylamino)-3-hydroxybutanoic acid
• CAS NO: 69489-07-2
• Molecular Formula: C9H17NO5
• Molecular Weight: 219.23
• Mol File: 69489-07-2.mol
• Article Data: 11

Chemical Properties

• Boiling Point: 411.8±40.0 °C(Predicted)
• Appearance: /
• Density: 1.204±0.06 g/cm3(Predicted)
• Storage Temp.: 2-8°C
• PKA: 4.30±0.10(Predicted)
• CAS DataBase Reference: BOC-4-AMINO-3-HYDROXYBUTANOIC ACID(CAS DataBase Reference)
• NIST Chemistry Reference: BOC-4-AMINO-3-HYDROXYBUTANOIC ACID(69489-07-2)
• EPA Substance Registry System: BOC-4-AMINO-3-HYDROXYBUTANOIC ACID(69489-07-2)

Safety Data

• HazardClass: IRRITANT
• Hazardous Substances Data: 69489-07-2(Hazardous Substances Data)

Usage

General Description

BOC-4-amino-3-hydroxybutanoic acid is a chemical compound that contains an amino group and a hydroxyl group on a four-carbon chain. It is commonly used as a building block in the synthesis of complex molecules and pharmaceuticals. The BOC (tert-butyloxycarbonyl) protecting group attached to the amino group serves to protect it from unwanted reactions during chemical synthesis. BOC-4-AMINO-3-HYDROXYBUTANOIC ACID has potential applications in the pharmaceutical industry, particularly in the development of drugs for neurological disorders and as a chiral building block for creating new molecules with specific biological activities. Additionally, the presence of the hydroxyl group makes it a potential precursor for the synthesis of other organic compounds and polymers.

Upstream product

• 181772-51-0 ethyl (3R)-4-(tert-butyloxycarbonyl)amino-3-hydroxybutanoate 
• 7013-05-0 (S)-4-amino-3-hydroxybutanoic acid 
• 24424-99-5 di-tert-butyl dicarbonate 
• 119960-04-2 methyl 4-[(tert-butoxycarbonyl)amino]-3-oxobutanoate 
• 4530-20-5 BOC-glycine 
• 34619-03-9 tert-butyldicarbonate 
• 87554-49-2 (R)-(-)-methyl N-t-butyloxycarbonyl-3-hydroxy-4-aminobutanoate 
• 924-49-2 DL-4-amino-3-hydroxybutyric acid 
• 847599-34-2 4-benzyloxy-1-tert-butyl-pyrrolidin-2-one 

Relevant articles and documents

HETEROCYCLIC GLP-1 AGONISTS

This disclosure relates to GLP-1 agonists of Formula (I), including pharmaceutically acceptable salts and solvates thereof, and pharmaceutical compositions including the same.

ISOXAZOLINE DERIVATIVES AS INSECTICIDAL COMPOUNDS

The present invention provides compounds of formula (I) wherein G1 is oxygen; R1 is hydrogen; R2 is group (P) L is a bond, methylene or ethylene; one of A1 and A2 is S, SO or SO2 and the other is -C(R4)R4-; R3 is hydrogen or methyl; each R4 is independently hydrogen or methyl; Y2 and Y3 are independently CH or nitrogen, wherein Y2 and Y3 are not both nitrogen; X2 is C-X6 or nitrogen; X1, X3 and X6 are independently hydrogen, halogen or trihalomethyl, wherein at least two of X1, X3 and X6 are not hydrogen; X4 is trifluoromethyl, difluoromethyl or chlorodifluoromethyl. The invention also provides intermediates useful for the preparation of compounds of formula (I), as well as methods of controlling insects, acarines, nematodes or molluscs using the compounds of formula (I).

ISOXAZOLINE DERIVATIVES AS INSECTICIDAL COMPOUNDS

The present invention provides compounds of formula (I) wherein G1 is oxygen; R1 is hydrogen; R2 is group P, L is a bond, methylene or ethylene; one of A1 and A2 is S, SO or SO2 and the other is -C(R4)R4-; R3 is hydrogen or methyl; each R4 is independently hydrogen or methyl; Y1, Y2 and Y3 are independently CH or nitrogen; wherein no more than two of Y1, Y2 and Y3 are nitrogen and wherein Y2 and Y3 are not both nitrogen; R5 is chloro, bromo, fluoro; X2 is C-X6 or nitrogen; Χ1, Χ3 and X6 are independently hydrogen, halogen or trihalomethyl, wherein at least two of X1, X3 and X6 are not hydrogen; X4 is trifluoromethyl, difluoromethyl or chlorodifluoromethyl. The invention also relates to methods of using the compounds to control insects, acarines, nematodes or molluscs, as well as intermediates usefor the the sysnthesis of the compounds.